Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-09-22
1979-01-23
Schwartz, Gerald A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2603405R, 260558H, 260558A, 560 34, 560142, 424282, 424311, 424324, 562439, A61K 31195, C07C10128
Patent
active
041361962
ABSTRACT:
A 2-hydrazono-propionic acid derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2, each independently is hydrogen, halogen, trifluoromethyl, alkyl, hydroxyl, acyloxy or alkoxy or together are methylenedioxy, and
REFERENCES:
patent: 3666801 (1972-05-01), Robinson
Chemical Abstracts, vol. 42, col. 7290(h), (1948).
Adnitt, "Diabetes", vol. 17, pp. 628-633.
Wickstrom et al., "The Lancet" pp. 995-997 (11/7/1964).
Van Praag et al., "Clinica Chimica Acta", vol. 8, pp. 466-475, (1963).
Haeckel Rainer
Heerdt Ruth
Hubner Manfred
Kuhnle Hans
Oellerich Michael
Boehringer Mannheim GmbH
Schwartz Gerald A.
LandOfFree
Hypoglycaemically active 2-(phenylalkyl- or -alkenyl hydrazono)- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycaemically active 2-(phenylalkyl- or -alkenyl hydrazono)-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycaemically active 2-(phenylalkyl- or -alkenyl hydrazono)- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2273519